Please fill out the Questionnaire

This is to ensure the appropriateness of treatment

Let’s Get You Scheduled For Your Consultation


I agree to terms & conditions. By providing my phone number, I agree to receive text messages from the business.

© Copyright 2024. Premier Infusions & Wellness. All rights reserved

© Copyright 2024. Premier Infusions & Wellness. All rights reserved

References:


Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations

• This article provides an overview of the efficacy and safety of semaglutide for chronic weight management. Read the article on PMC - NCBI


Once-Weekly Semaglutide in Adults with Overweight or Obesity

• Published in the New England Journal of Medicine, this study examines the effects of once-weekly subcutaneous semaglutide on adults with overweight or obesity.  Read the study on NEJM


Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

• This trial, featured in Nature Medicine, assesses the efficacy and safety of once-weekly subcutaneous semaglutide over a two-year period.  Read the study on Nature Medicine


Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial

• The Lancet presents the OASIS 1 trial, which shows the effects of daily oral semaglutide on adults with overweight or obesity.  Read the study on The Lancet


Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

• This cohort study, published by JAMA Network, suggests that semaglutide is clinically effective for weight loss at 3 and 6 months for people with overweight or obesity.  Read the study on JAMA Network